Product Reports Resources Pricing Login Book a demo

Acurable

Health Tech & Medtech · London, United Kingdom · Founded 2016

Wearable acoustic sensors for automated respiratory condition diagnosis MoreLess

Acurable is a medical device company with offices in London and Seville that develops wearable sensors for at-home medical diagnosis. The company was founded in 2016 by Professor Esther Rodriguez-Villegas, Emilio Sanz Pereiras, and Dr. Anas Imtiaz, spinning out of Imperial College London.

The founding technology was the result of over a decade of research led by Professor Rodriguez-Villegas at the university's Wearable Technologies Lab. The initial research, which started in 2004, was prompted by a request to develop an apnoea monitoring technology to help prevent Sudden Unexpected Death in Epilepsy (SUDEP). This led to a multidisciplinary research journey that uncovered solutions for broader respiratory and cardiovascular diseases. Professor Rodriguez-Villegas, a Spanish engineer and inventor, is a Professor of Low Power Electronics at Imperial College London and a Fellow of the Royal Academy of Engineering.

Acurable's core technology, AcuPebble, uses non-invasive acoustic sensors that are worn on the neck to record physiological sounds like breathing and cardiac functions. These signals are sent to a mobile device and then to the cloud, where proprietary algorithms analyze the data to extract key diagnostic parameters, automating the analysis and providing instant results for clinicians. This process aims to reduce clinician workload and allow for remote patient monitoring.

The company's first product, AcuPebble SA100, is designed for the automated diagnosis of obstructive sleep apnoea (OSA). It received a CE mark in Europe in 2020 and 510(k) clearance from the U.S. Food and Drug Administration (FDA) in 2021. Acurable operates on both a service license model, where it manages the diagnostic process, and a product license model, where healthcare providers like the NHS manage it themselves. The company's clients are healthcare organizations and its devices are used in clinical trials. Acurable has raised funds through various rounds, including a seed round in 2017 and a Series A round of €11 million in 2022, led by Kibo Ventures.

Keywords: wearable medical devices, acoustic sensing, home sleep testing, obstructive sleep apnoea, respiratory monitoring, MedTech, remote diagnostics, physiological monitoring, digital health, CE mark, FDA clearance, Esther Rodriguez-Villegas, Imperial College London, AcuPebble, cardiovascular disease management, automated diagnosis, patient monitoring, biosignal processing, cloud algorithms, telemedicine

Company overview

Acurable company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2016
Headquarters
London, United Kingdom
Employees
31
Open positions
None listed
Dealroom signal
70.1
client focusb2btechnologyArtificial IntelligencetechnologyHardwaretechnologyDeep TechtechnologyComputer VisiontechnologyConnected Devicesub industryMedical Devicessub industryHealth Platformbusiness modelManufacturingindustryHealthsectorRemote MonitoringsectorCore AIsectorNon-Invasive medical devices and treatmentssectorSpinout

Valuation & funding

Acurable funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AEquity / VC Oct 2022 $12M $48M Mundi Ventures · Comprador Holdings · Kindred Capital · Kibo Ventures
SUPPORT PROGRAMOther financing Sep 2021 $0 Tech Nation
GRANTOther financing Jun 2020 $264K Undisclosed
GRANTOther financing Jan 2019 $1.5M Undisclosed
SEEDEquity / VC Sep 2017 $2.8M $11M Kindred Capital · Mundi Ventures
SPINOUTOther financing Aug 2016 College of Medicine and Integrated Health · Imperial College London
Showing 6 recorded eventsUnlock the complete deal history →

Financials

Workforce over time

Available workforce history. Financial fields without reported data are omitted.

YearEmployees
2026 31
2025 32
2024 29
2023 29
2022 16
2021 12
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Acurable website traffic

Latest recorded traffic for Acurable is 1.4K monthly website visits, down 68.2% over the last three months. Acurable's team declined 3.1% over the past year.

Latest monthly visits1.4K 3-month web change-68.2% 1-year team growth-3.1%
Monthly website visits97 observations · Mar 2018–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Acurable compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Acurable's talent

Book a demo to see the people
Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

7 investors on Acurable's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 2 investors entered at this stage
Mundi Ventures
Kindred Capital
Series A 2 investors entered at this stage
Kibo Ventures
Comprador Holdings
Other known 3 additional known investors
College of Medicine and Integrated Health
Imperial College London
Tech Nation

Global footprint

Where Acurable has talent and traffic

Workforce by country
2 countries with
team presence
🇬🇧 United Kingdom91.3%
🇪🇸 Spain8.7%
2 countries shown

In the news

Latest news about Acurable

Recent press, funding announcements, and product moves mentioning Acurable — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Acurable

An AI-synthesized read of the highest-engagement posts about Acurable on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Acurable’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.